美国食品药品监督管理局批准丁丙诺啡-纳洛酮用于门诊成瘾治疗。 - Suppr

Suppr

超能文献

Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

作者信息

Resnick Richard B

出版信息

Ann Intern Med. 2003 Feb 18;138(4):360. doi: 10.7326/0003-4819-138-4-200302180-00027.

DOI:10.7326/0003-4819-138-4-200302180-00027

PMID:12585846

Abstract

摘要

相似文献

Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

Ann Intern Med. 2003 Feb 18;138(4):360. doi: 10.7326/0003-4819-138-4-200302180-00027.

Drugs approved for opiate dependence.

FDA Consum. 2003 Jan-Feb;37(1):6.

Office-based practice and opioid-use disorders.

N Engl J Med. 2003 Sep 4;349(10):928-30. doi: 10.1056/NEJMp038126.

In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.

Med Lett Drugs Ther. 2013 Oct 14;55(1427):83.

Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S103-4. doi: 10.1016/s0376-8716(03)00063-2.

From the Food and Drug Administration.

JAMA. 2002 Dec 4;288(21):2678.

Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?

J Manag Care Pharm. 2008 Mar;14(2):195-7. doi: 10.18553/jmcp.2008.14.2.195.

Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.

N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059.

Counseling buprenorphine patients: information and treatment approaches for counselors.

J Psychoactive Drugs. 2004 May;Suppl 2:139-46. doi: 10.1080/02791072.2004.10400049.

Buprenorphine maintenance: a new treatment for opioid dependence.

Cleve Clin J Med. 2007 Jul;74(7):514-20. doi: 10.3949/ccjm.74.7.514.

引用本文的文献

Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

J Natl Med Assoc. 2012 Jul-Aug;104(7-8):342-50. doi: 10.1016/s0027-9684(15)30175-9.

Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.

Behav Pharmacol. 2006 Mar;17(2):151-9. doi: 10.1097/01.fbp.0000197459.08892.b5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

Ann Intern Med. 2003 Feb 18;138(4):360. doi: 10.7326/0003-4819-138-4-200302180-00027.

Drugs approved for opiate dependence.

FDA Consum. 2003 Jan-Feb;37(1):6.

Office-based practice and opioid-use disorders.

N Engl J Med. 2003 Sep 4;349(10):928-30. doi: 10.1056/NEJMp038126.

In brief: Buprenorphine/naloxone (Zubsolv) for opioid dependence.

Med Lett Drugs Ther. 2013 Oct 14;55(1427):83.

Accessing opiate dependence treatment medications: buprenorphine products in an office-based setting.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S103-4. doi: 10.1016/s0376-8716(03)00063-2.

From the Food and Drug Administration.

JAMA. 2002 Dec 4;288(21):2678.

Is buprenorphine-naloxone ready for prime time in the treatment of opioid addiction in managed care?

J Manag Care Pharm. 2008 Mar;14(2):195-7. doi: 10.18553/jmcp.2008.14.2.195.

Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.

N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059.

Counseling buprenorphine patients: information and treatment approaches for counselors.

J Psychoactive Drugs. 2004 May;Suppl 2:139-46. doi: 10.1080/02791072.2004.10400049.

Buprenorphine maintenance: a new treatment for opioid dependence.

Cleve Clin J Med. 2007 Jul;74(7):514-20. doi: 10.3949/ccjm.74.7.514.

引用本文的文献

Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options.

J Natl Med Assoc. 2012 Jul-Aug;104(7-8):342-50. doi: 10.1016/s0027-9684(15)30175-9.

Effects of monoamine oxidase inhibitors on cocaine discrimination in rats.

Behav Pharmacol. 2006 Mar;17(2):151-9. doi: 10.1097/01.fbp.0000197459.08892.b5.

Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

作者信息

Resnick Richard B

出版信息

Ann Intern Med. 2003 Feb 18;138(4):360. doi: 10.7326/0003-4819-138-4-200302180-00027.

DOI:10.7326/0003-4819-138-4-200302180-00027

PMID:12585846

Abstract

摘要